These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 9871431
1. Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole. Greenblatt DJ, von Moltke LL, Harmatz JS, Mertzanis P, Graf JA, Durol AL, Counihan M, Roth-Schechter B, Shader RI. Clin Pharmacol Ther; 1998 Dec; 64(6):661-71. PubMed ID: 9871431 [Abstract] [Full Text] [Related]
2. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences. Greenblatt DJ, Wright CE, von Moltke LL, Harmatz JS, Ehrenberg BL, Harrel LM, Corbett K, Counihan M, Tobias S, Shader RI. Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147 [Abstract] [Full Text] [Related]
3. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. Greenblatt DJ, Harmatz JS, von Moltke LL, Wright CE, Durol AL, Harrel-Joseph LM, Shader RI. J Pharmacol Exp Ther; 2000 May; 293(2):435-43. PubMed ID: 10773013 [Abstract] [Full Text] [Related]
4. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. Greenblatt DJ, Harmatz JS, von Moltke LL, Ehrenberg BL, Harrel L, Corbett K, Counihan M, Graf JA, Darwish M, Mertzanis P, Martin PT, Cevallos WH, Shader RI. Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048 [Abstract] [Full Text] [Related]
5. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. von Moltke LL, Greenblatt DJ, Harmatz JS, Duan SX, Harrel LM, Cotreau-Bibbo MM, Pritchard GA, Wright CE, Shader RI. J Pharmacol Exp Ther; 1996 Feb; 276(2):370-9. PubMed ID: 8632299 [Abstract] [Full Text] [Related]
8. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect. Varis T, Kivistö KT, Backman JT, Neuvonen PJ. Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751 [Abstract] [Full Text] [Related]
9. The triazole antifungal agents: a review of itraconazole and fluconazole. Bailey EM, Krakovsky DJ, Rybak MJ. Pharmacotherapy; 1990 Nov; 10(2):146-53. PubMed ID: 2161523 [Abstract] [Full Text] [Related]
10. The effect of ingestion time interval on the interaction between itraconazole and triazolam. Neuvonen PJ, Varhe A, Olkkola KT. Clin Pharmacol Ther; 1996 Sep; 60(3):326-31. PubMed ID: 8841155 [Abstract] [Full Text] [Related]
11. 150 mg fluconazole does not substantially increase the effects of 10 mg midazolam or the plasma midazolam concentrations in healthy subjects. Vanakoski J, Mattila MJ, Vainio P, Idänpään-Heikkilä JJ, Törnwall M. Int J Clin Pharmacol Ther; 1995 Sep; 33(9):518-23. PubMed ID: 8520811 [Abstract] [Full Text] [Related]
12. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs. Venkateswarlu K, Denning DW, Kelly SL. J Med Vet Mycol; 1997 Sep; 35(1):19-25. PubMed ID: 9061581 [Abstract] [Full Text] [Related]
13. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Otmani S, Demazières A, Staner C, Jacob N, Nir T, Zisapel N, Staner L. Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235 [Abstract] [Full Text] [Related]
14. Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo. Greenblatt DJ, Legangneux E, Harmatz JS, Weinling E, Freeman J, Rice K, Zammit GK. J Clin Pharmacol; 2006 Dec; 46(12):1469-80. PubMed ID: 17101746 [Abstract] [Full Text] [Related]
15. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem. Luurila H, Kivistö KT, Neuvonen PJ. Eur J Clin Pharmacol; 1998 Apr; 54(2):163-6. PubMed ID: 9626922 [Abstract] [Full Text] [Related]
16. Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem. Farkas D, Volak LP, Harmatz JS, von Moltke LL, Court MH, Greenblatt DJ. Clin Pharmacol Ther; 2009 Jun; 85(6):644-50. PubMed ID: 19242403 [Abstract] [Full Text] [Related]
17. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance. Weinling E, McDougall S, Andre F, Bianchetti G, Dubruc C. Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025 [Abstract] [Full Text] [Related]
18. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin. Mazzu AL, Lasseter KC, Shamblen EC, Agarwal V, Lettieri J, Sundaresen P. Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579 [Abstract] [Full Text] [Related]
19. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers. Blin O, Micallef J, Audebert C, Legangneux E. J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893 [Abstract] [Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Cysneiros RM, Farkas D, Harmatz JS, von Moltke LL, Greenblatt DJ. Clin Pharmacol Ther; 2007 Jul; 82(1):54-62. PubMed ID: 17443132 [Abstract] [Full Text] [Related] Page: [Next] [New Search]